Maintenance therapy with trabectedin versus observation after first line treatment with
doxorubicin of patients with advanced or metastatic soft tissue sarcoma.
This is a prospective, multicenter, randomized, open label Phase III trial investigating
whether a maintenance treatment with trabectedin, as compared to the observational approach,
can prolong progression-free survival in patients with advanced, inoperable and/or metastatic
STS after response or stabilisation during first line treatment with doxorubicin.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC